{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:46:01Z","timestamp":1790189161723,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>: Tourette syndrome (TS) is a neuropsychiatric disorder with onset in childhood that warrants effective therapies. Gut microbiota can affect central physiology and function via the microbiota\u2013gut-brain axis. Therefore, the gut microbiota plays an important role in some mental illnesses. A small clinical trial showed that fecal microbiota transplantation (FMT) may alleviate TS symptoms in children. Herein, FMT effects and mechanisms were explored in a TS mouse model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>: TS mice model (TSMO) <jats:italic toggle=\"yes\">(n<\/jats:italic>\u200a=\u200a80) were established with 3,3\u2032-iminodipropionitrile, and 80 mice were used as controls. Mice were grouped into eight groups and were subjected to FMT with feces from children or mice with or without TS, or were given probiotics. Fecal specimens were collected 3 weeks after FMT. <jats:italic toggle=\"yes\">16S<\/jats:italic> rRNA sequencing, behavioral observation, and serum serotonin (5-HT) assay were performed. Differences between groups were analyzed using Mann-Whitney <jats:italic toggle=\"yes\">U<\/jats:italic> test and Kolmogorov-Smirnov (KS) tests.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>: A total of 18 discriminative microbial signatures (linear discriminant analysis score\u200a&gt;\u200a3) that varied significantly between TS and healthy mice (CONH) were identified. A significant increase in <jats:italic toggle=\"yes\">Turicibacteraceae<\/jats:italic> and <jats:italic toggle=\"yes\">Ruminococcaceae<\/jats:italic> in TSMO after FMT was observed <jats:italic toggle=\"yes\">(P<\/jats:italic>\u200a\n                                 <jats:italic toggle=\"yes\">&lt;<\/jats:italic>\u200a0.05). Compared with non-transplanted TSMO, the symptoms of those transplanted with feces from CONH were alleviated (<jats:italic toggle=\"yes\">W<\/jats:italic>\u200a=\u200a336, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.046). In the probiotic and FMT experiments, the serum 5-HT levels significantly increased in TSMO that received probiotics (KS\u200a=\u200a1.423, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.035) and in those transplanted with feces from CONH (<jats:italic toggle=\"yes\">W<\/jats:italic>\u200a=\u200a336.5, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.046) compared with TSMO without transplantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>: This study suggests that FMT may ameliorate TS by promoting 5-HT secretion, and it provides new insights into the underlying mechanisms of FMT as a treatment for TS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000001885","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T09:03:41Z","timestamp":1647335021000},"page":"707-713","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":32,"title":["Fecal transplantation can alleviate tic severity in a Tourette syndrome mouse model by modulating intestinal flora and promoting serotonin secretion"],"prefix":"10.1097","volume":"135","author":[{"given":"Hua","family":"Li","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Cheeloo Children's Hospital, Shandong University, Jinan, Shandong 250022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, School of Stomatology and Medicine, Foshan University, Chancheng District, Foshan, Guangdong 528000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changying","family":"Zhao","sequence":"additional","affiliation":[{"name":"Jinan Institute of Paediatric Medicine, Cheeloo Children's Hospital, Shandong University, Jinan, Shandong 250022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[{"name":"Jinan Institute of Paediatric Medicine, Cheeloo Children's Hospital, Shandong University, Jinan, Shandong 250022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Microbiome-X, National Institute of Health Data Science of China, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,20]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-005-0008-8","article-title":"Tic disorders: from pathophysiology to treatment","volume":"253","author":"Rampello","year":"2006","journal-title":"J Neurol"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"f4964","DOI":"10.1136\/bmj.f4964","article-title":"Tourette's syndrome","volume":"347","author":"Cavanna","year":"2013","journal-title":"BMJ"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/mds.23618","article-title":"Tourette syndrome: evolving concepts","volume":"26","author":"Jankovic","year":"2011","journal-title":"Mov Disord"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2012.05.002","article-title":"Prevalence of tic disorders: a systematic review and meta-analysis","volume":"47","author":"Knight","year":"2012","journal-title":"Pediatr Neurol"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jaac.2013.09.015","article-title":"American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders","volume":"52","author":"Murphy","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.neubiorev.2012.09.008","article-title":"Systematic review: pharmacological treatment of tic disorders - efficacy of antipsychotic and alpha-2 adrenergic agonist agents","volume":"37","author":"Weisman","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hup.2495","article-title":"Serial pharmacological prescribing practices for tic management in Tourette syndrome","volume":"30","author":"Farag","year":"2015","journal-title":"Hum Psychopharmacol"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.26094","article-title":"Tourette syndrome deep brain stimulation: a review and updated recommendations","volume":"30","author":"Schrock","year":"2015","journal-title":"Mov Disord"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.neubiorev.2012.11.004","article-title":"The functional anatomy of Gilles de la Tourette syndrome","volume":"37","author":"Ganos","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","article-title":"Gut microbiome alterations in Alzheimer's disease","volume":"7","author":"Vogt","year":"2017","journal-title":"Sci Rep"},{"key":"R12-20250603","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann Gastroenterol"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol Rev"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","article-title":"The central nervous system and the gut microbiome","volume":"167","author":"Sharon","year":"2016","journal-title":"Cell"},{"key":"R15-20250603","first-page":"10","article-title":"Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study","volume":"5","author":"Kang","year":"2017","journal-title":"Micro-biome"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.3748\/wjg.v23.i19.3565","article-title":"Fecal microbiota transplantation cured epilepsy in a case with Crohn's disease: the first report","volume":"23","author":"He","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R17-20250603","first-page":"221","article-title":"A new animal model for Tourette syndrome","volume":"35","author":"Diamond","year":"1982","journal-title":"Adv Neurol"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fnbeh.2019.00239","article-title":"Effects of acupuncture on behavioral stereotypies and brain dopamine system in mice as a model of Tourette syndrome","volume":"13","author":"Lin","year":"2019","journal-title":"Front Behav Neurosci"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s13238-018-0541-8","article-title":"Microbiota transplantation: concept, methodology and strategy for its modernization","volume":"9","author":"Zhang","year":"2018","journal-title":"Protein Cell"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat Methods"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"D141","DOI":"10.1093\/nar\/gkn879","article-title":"The ribosomal database project: improved alignments and new tools for rRNA analysis","volume":"37","author":"Cole","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences","volume":"31","author":"Langille","year":"2013","journal-title":"Nat Biotechnol"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","article-title":"Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data","volume":"8","author":"McMurdie","year":"2013","journal-title":"PLoS One"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/microorganisms8030406","article-title":"Investigating the gut microbiota composition of individuals with attention-deficit\/hyperactivity disorder and association with symptoms","volume":"8","author":"Szopinska-Tokov","year":"2020","journal-title":"Microorganisms"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40168-017-0242-1","article-title":"New evidences on the altered gut microbiota in autism spectrum disorders","volume":"5","author":"Strati","year":"2017","journal-title":"Microbiome"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"e24585","DOI":"10.1371\/journal.pone.0024585","article-title":"Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances","volume":"6","author":"Williams","year":"2011","journal-title":"PLoS One"},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2180-9-123","article-title":"The firmicutes\/bacteroidetes ratio of the human microbiota changes with age","volume":"9","author":"Mariat","year":"2009","journal-title":"BMC Microbiol"},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"e68322","DOI":"10.1371\/journal.pone.0068322","article-title":"Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children","volume":"8","author":"Kang","year":"2013","journal-title":"PLoS One"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","article-title":"Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease","volume":"65","author":"Quevrain","year":"2016","journal-title":"Gut"},{"key":"R30-20250603","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.phrs.2017.12.009","article-title":"Alzheimer's disease and gut microbiota modifications: the long way between preclinical studies and clinical evidence","volume":"129","author":"Mancuso","year":"2018","journal-title":"Pharmacol Res"},{"key":"R31-20250603","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","article-title":"Proteobacteria: microbial signature of dysbiosis in gut microbiota","volume":"33","author":"Shin","year":"2015","journal-title":"Trends Biotechnol"},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"6165239","DOI":"10.1155\/2017\/6165239","article-title":"The effect of fecal microbiota transplantation on a child with Tourette syndrome","volume":"2017","author":"Zhao","year":"2017","journal-title":"Case Rep Med"},{"key":"R33-20250603","doi-asserted-by":"crossref","first-page":"554441","DOI":"10.3389\/fpsyt.2020.554441","article-title":"The efficacy of fecal microbiota transplantation for children with Tourette syndrome: a preliminary study","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Psychiatry"},{"key":"R34-20250603","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.npp.1301528","article-title":"Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET","volume":"33","author":"Wong","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R35-20250603","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41598-018-37710-4","article-title":"Serotonin transporter binding is increased in Tourette syndrome with obsessive compulsive disorder","volume":"9","author":"Muller-Vahl","year":"2019","journal-title":"Sci Rep"},{"key":"R36-20250603","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2005.05.031","article-title":"Serotonin transporter binding in Tourette syndrome","volume":"385","author":"Muller-Vahl","year":"2005","journal-title":"Neurosci Lett"},{"key":"R37-20250603","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1038\/npp.2008.35","article-title":"Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder","volume":"33","author":"Zitterl","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R38-20250603","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000090702","article-title":"Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder","volume":"53","author":"Stengler-Wenzke","year":"2006","journal-title":"Neuropsychobiology"},{"key":"R39-20250603","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fnins.2019.01365","article-title":"Tryptophan metabolism by gut microbiome and gut-brain-axis: an in silico analysis","volume":"13","author":"Kaur","year":"2019","journal-title":"Front Neurosci"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:03:31Z","timestamp":1748977411000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000001885","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]}}}